About Idarucizumab
            
            Class: | Monoclonal antibody (specific reversal agent for dabigatran)  
Use: | Reversal of anticoagulation effects of dabigatran in patients requiring urgent surgical intervention or experiencing life-threatening or uncontrolled bleeding  
Adult dose: | 5 g (administered as two 2.5 g intravenous infusions or boluses)  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | Hypersensitivity reactions, headache, dizziness,
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (specific reversal agent for dabigatran)
                 
                
                
                    
                        Uses & Indications
                    
                    Reversal of anticoagulation effects of dabigatran in patients requiring urgent surgical intervention or experiencing life-threatening or uncontrolled bleeding
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; can be stored at room temperature (up to 25°C or 77°F) for up to 24 hours prior to use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Boehringer Ingelheim International GmbH, GERMANY
                    
                    
                    Package Size
                    Kit of 2.5 g/50 ml Vial x 2s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 13934.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        5 g (administered as two 2.5 g intravenous infusions or boluses)
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Hypersensitivity reactions, headache, dizziness, nausea, constipation, and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to idarucizumab or any of its components; caution in patients with a history of severe allergic reactions
         
        
        
            
                Important Warnings
            
            Risk of thromboembolic events upon reversal of dabigatran; monitor for signs of bleeding; not indicated for patients not taking dabigatran; use with caution in patients with renal impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.